Advertisement

Indian Pediatrics

, Volume 54, Issue 10, pp 813–816 | Cite as

Editorials

  • Pavitra Mohan
  • Sanjana Brahmawar Mohan
  • Aditi Sinha
  • Arvind Bagga
Article

References

  1. 1.
    International Institute for Population Sciences (IIPS) and Macro International. 2016. National Family Health Survey (NFHS-4), 2015–16: India Fact Sheet. Mumbai: IIPS.Google Scholar
  2. 2.
    Olofin I, McDonald CM, Ezzali M, Flaxman S, Black RE, Fawzi WW, et al. Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies. PloS One. 2013;8:e64636.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Sachdev HPS, Sinha S, Sareen N, Pandey RM, Kapil U. Survival and recovery in severely wasted under-five children without community management of acute malnutrition programme. Indian Pediatr. 2017;54:817–23.CrossRefGoogle Scholar
  4. 4.
    Bhandari N, Mohan SB, Bose A, Iyengar SD, Taneja S, Mazumder S, et al. Efficacy of three feeding regimens for home based management of children with uncomplicated severe acute malnutrition: a randomised trial in India. BMJ Glob Health. 2016;1:e000144.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    International Institute for Population Sciences (IIPS) and Macro International. 2016. National Family Health Survey (NFHS-4), 2015-16: District Fact Sheet Meerut Uttar Pradesh. Mumbai: IIPS.Google Scholar
  6. 6.
    Indian Academy of Pediatrics. Consensus Statement of the Indian Academy of Pediatrics on integrated management of severe acute malnutrition. Indian Pediatr. 2013;15;16:399–404.Google Scholar
  7. 7.
    Khanum S, Ashworth A, Huttly SR. Growth, morbidity and mortality of children in Dhaka after treatment for severe malnutrition: a prospective study. Am J Clin Nutr. 1998;67:940–5.PubMedGoogle Scholar
  8. 8.
    Kerac M, Bunn J, Seal A, Thindwa M, Tomkins A, Sadler K, et al. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet. 2009;11;374(9684):136–44.CrossRefGoogle Scholar
  9. 9.
    UNICEF. Malnutrition in South Asia: A Regional Profile. Gillespie S (Ed). Regional Office for South Asia. Kathmandu, Nepal. 1997.Google Scholar

References

  1. 1.
    El Bakkali L, Rodrigues Pereira R, Kuik DJ, Ket JC, van Wijk JA. Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature. Pediatr Nephrol. 2011;26:1241–6.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13–28.PubMedGoogle Scholar
  3. 3.
    Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics. Indian Pediatr. 2008;45:203–14.Google Scholar
  4. 4.
    Lombel RM, Gipson DS, Hodson EM; Kidney Disease: Improving Global Outcomes. Treatment of steroidsensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol. 2013;28:415–26.CrossRefPubMedGoogle Scholar
  5. 5.
    Pravitsitthikul N, Willis NS, Hodson EM, Craig JC. Noncorticosteroid immunosuppressive medications for steroidsensitive nephrotic syndrome in children. Cochrane Database Syst Rev. 2013;10:CD002290.Google Scholar
  6. 6.
    Fu Y, Wang T, Xiu L, Shi X, Bian Z, Zhang Y, et al. Levamisole promotes murine bone marrow derived dendritic cell activation and drives Th1 immune response in vitro and in vivo. Int Immunopharmacol. 2016;31:57–65.CrossRefPubMedGoogle Scholar
  7. 7.
    Jiang L, Dasgupta I, Hurcombe JA, Colyer HF, Mathieson PW, Welsh GI. Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte. Clin Sci (Lond). 2015;128:883–93.CrossRefPubMedGoogle Scholar
  8. 8.
    Sinha A, Puraswani M, Rawat M, Hari P, Bagga A. RCT comparing mycophenolate mofetil and levamisole in frequently relapsing nephrotic syndrome. Pediatr Nephrol. 2014;29(S10):2434.Google Scholar
  9. 9.
    Gruppen M, Davin JC, Bouts A. Levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome: Results of a multi-center, doubleblind, placebo-controlled, randomized clinical trial. Pediatr Nephrol. 2016;31:1753.Google Scholar
  10. 10.
    Samual EMK, Krishnamurthy S, Bhanudeep S, Muske S. Levamisole in frequently-relapsing and steroid-dependent nephrotic syndrome. Indian Pediatr. 2017;54:831–34.CrossRefGoogle Scholar
  11. 11.
    Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S. Efficacy of levamisole in children with frequently relapsing and steroiddependent nephrotic syndrome. Indian Pediatr. 2014;51:371–3.CrossRefPubMedGoogle Scholar
  12. 12.
    Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr. 1993;152:357–61.PubMedGoogle Scholar
  13. 13.
    Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2007;4:CD001533.Google Scholar
  14. 14.
    Larkins N, Kim S, Craig J, Hodson E. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child. 2016;101:404–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Webb N, Wooley R, Brettell E, Cummins C, Trompeter R, Barsoum E, et al.; on behalf of the PREDNOS investigators. Standard vs. extended course prednisolone therapy for the presenting episode of steroid sensitive nephrotic syndrome: PREDNOS Study. Pediatr Nephrol. 2017;32:1647.CrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2017

Authors and Affiliations

  • Pavitra Mohan
    • 1
  • Sanjana Brahmawar Mohan
    • 1
  • Aditi Sinha
    • 2
  • Arvind Bagga
    • 2
  1. 1.Aajeevika Bureau and Basic Health Care ServicesUdaipurIndia
  2. 2.Department of Pediatrics, ICMR Center for Advanced Research in NephrologyAIIMSNew DelhiIndia

Personalised recommendations